In Vitro Diagnostics Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global In Vitro Diagnostics market garnered revenue around USD 69,213 million in 2020 and projected to reach USD 93,190 million in 2027, with at a compound annual growth rate (CAGR) 5.7% throughout the estimate period from 2021 to 2027. In vitro diagnostics (IVD) are medical devices, which require use of assays and reagents to diagnose a medical condition. Moreover, these instruments analyze body fluids and tissue samples collected from a patient. In addition, there are various types of in vitro diagnostic instruments that work on different techniques such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics. Furthermore, in vitro diagnostics are employed in diagnosis of various medical conditions such as infectious diseases, cancer, cardiac disorders, and nephrological disorders.  Moreover, use and handling of in vitro diagnostics require technical expertise and thus, instruments are used in specialized medical facilities to carry out diagnosis. For instance, IVD products are used in facilities such as standalone laboratories, hospitals, and point-of care. 

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the In Vitro Diagnostics market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the In Vitro Diagnostics market growth.

The global In Vitro Diagnostics market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The global in vitro diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum in vitro diagnostics market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Product & Service

·         Reagents

·         Instruments

·         Software and Services

By Technique

·         Immunodiagnostics

o    Enzyme-Linked Immunosorbent Assay (ELISA)

§  Chemiluminescence Immunoassay (CLIA)

§  Fluorescence immunoassay (FIA)    

§  Colorimetric Immunoassay (CI)

  •         Rapid Tests
  •         Enzyme-Linked ImmunoSpot (ELISPOT)    
  •         Radioimmunoassay (RIA)
  •         Western Blot
  •         Hematology
  •        Molecular Diagnostics
  •          Polymerize Chain Reaction (PCR)
  •     I  sothermal Nucleic Acid Amplification Technology (INAAT)
  •          Hybridization
  •         DNA diagnostics
  •         Microarray
  •         Others

·         Tissue Diagnostics

·         Clinical Chemistry

o    Basic Metabolic Panel

o    Liver Panel

o    Lipid Profile

o    Thyroid Function Panel

o    Electrolyte Panel    

o    Specialty Chemicals

·         Others

By Application

·         Infectious Diseases

·         Cancer

·         Cardiac Diseases

·         Immune System Disorders

·         Nephrological Diseases 

·         Gastrointestinal Diseases

·         Others

By End User 

·         Standalone Laboratories

·         Hospitals

·         Academic & Medical Schools

·         Point-of-Care

·         Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

 

North America

United States

Canada

 

Europe

Germany

United Kingdom

Italy

France

Rest of EU

 

Asia Pacific

China

India

Japan

Southeast Asia

Rest of APAC

 

Central & South America 

Brazil 

Argentina

Rest of Central & South America 

 

Middle East and Africa

GCC

North Africa

South Africa

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global In Vitro Diagnostics Market, By Product & Service

7.1.  In Vitro Diagnostics Market, by Product & Service, 2020-2027

7.1.1.    Reagents

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Instruments

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Software and Services

7.1.3.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global In Vitro Diagnostics Market, By Technique

8.1.  In Vitro Diagnostics Market, by Technique, 2020-2027

8.1.1.    Immunodiagnostics

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Hematology

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Molecular Diagnostics

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Tissue Diagnostics

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Clinical Chemistry

8.1.5.1.        Market Revenue and Forecast (2016-2027)

8.1.6.    Others

8.1.6.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global In Vitro Diagnostics Market, By Application

9.1.  In Vitro Diagnostics Market, by Application, 2020-2027

9.1.1.    Infectious Diseases

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Cancer

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Cardiac Diseases

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Immune System Disorders

9.1.4.1.        Market Revenue and Forecast (2016-2027)

9.1.5.    Nephrological Diseases

9.1.5.1.        Market Revenue and Forecast (2016-2027)

9.1.6.    Gastrointestinal Diseases

9.1.6.1.        Market Revenue and Forecast (2016-2027)

9.1.7.    Others

9.1.7.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global In Vitro Diagnostics Market, By End User

10.1.        In Vitro Diagnostics Market, by End User, 2020-2027

10.1.1.  Standalone Laboratories

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  Hospitals

10.1.2.1.      Market Revenue and Forecast (2016-2027)

10.1.3.  Academic & Medical Schools

10.1.3.1.      Market Revenue and Forecast (2016-2027)

10.1.4.  Point-of-Care

10.1.4.1.      Market Revenue and Forecast (2016-2027)

10.1.5.  Others

10.1.5.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global In Vitro Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

11.1.2.  Market Revenue and Forecast, by Technique (2016-2027)

11.1.3.  Market Revenue and Forecast, by Application (2016-2027)

11.1.4.  Market Revenue and Forecast, by End User (2016-2027)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.1.5.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.1.5.3.      Market Revenue and Forecast, by Application (2016-2027)

11.1.5.4.      Market Revenue and Forecast, by End User (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.1.6.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.1.6.3.      Market Revenue and Forecast, by Application (2016-2027)

11.1.6.4.      Market Revenue and Forecast, by End User (2016-2027)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

11.2.2.  Market Revenue and Forecast, by Technique (2016-2027)

11.2.3.  Market Revenue and Forecast, by Application (2016-2027)

11.2.4.  Market Revenue and Forecast, by End User (2016-2027)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.2.5.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.2.5.3.      Market Revenue and Forecast, by Application (2016-2027)

11.2.5.4.      Market Revenue and Forecast, by End User (2016-2027)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product & Service(2016-2027)

11.2.6.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.2.6.3.      Market Revenue and Forecast, by Application (2016-2027)

11.2.6.4.      Market Revenue and Forecast, by End User (2016-2027)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.2.7.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.2.7.3.      Market Revenue and Forecast, by Application (2016-2027)

11.2.7.4.      Market Revenue and Forecast, by End User (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.2.8.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.2.8.3.      Market Revenue and Forecast, by Application (2016-2027)

11.2.8.4.      Market Revenue and Forecast, by End User (2016-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

11.3.2.  Market Revenue and Forecast, by Technique (2016-2027)

11.3.3.  Market Revenue and Forecast, by Application (2016-2027)

11.3.4.  Market Revenue and Forecast, by End User (2016-2027)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.3.5.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.3.5.3.      Market Revenue and Forecast, by Application (2016-2027)

11.3.5.4.      Market Revenue and Forecast, by End User (2016-2027)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.3.6.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.3.6.3.      Market Revenue and Forecast, by Application (2016-2027)

11.3.6.4.      Market Revenue and Forecast, by End User (2016-2027)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.3.7.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.3.7.3.      Market Revenue and Forecast, by Application (2016-2027)

11.3.7.4.      Market Revenue and Forecast, by End User (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.3.8.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.3.8.3.      Market Revenue and Forecast, by Application (2016-2027)

11.3.8.4.      Market Revenue and Forecast, by End User (2016-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

11.4.2.  Market Revenue and Forecast, by Technique (2016-2027)

11.4.3.  Market Revenue and Forecast, by Application (2016-2027)

11.4.4.  Market Revenue and Forecast, by End User (2016-2027)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.4.5.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.4.5.3.      Market Revenue and Forecast, by Application (2016-2027)

11.4.5.4.      Market Revenue and Forecast, by End User (2016-2027)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.4.6.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.4.6.3.      Market Revenue and Forecast, by Application (2016-2027)

11.4.6.4.      Market Revenue and Forecast, by End User (2016-2027)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.4.7.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.4.7.3.      Market Revenue and Forecast, by Application (2016-2027)

11.4.7.4.      Market Revenue and Forecast, by End User (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.4.8.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.4.8.3.      Market Revenue and Forecast, by Application (2016-2027)

11.4.8.4.      Market Revenue and Forecast, by End User (2016-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

11.5.2.  Market Revenue and Forecast, by Technique (2016-2027)

11.5.3.  Market Revenue and Forecast, by Application (2016-2027)

11.5.4.  Market Revenue and Forecast, by End User (2016-2027)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.5.5.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.5.5.3.      Market Revenue and Forecast, by Application (2016-2027)

11.5.5.4.      Market Revenue and Forecast, by End User (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product & Service (2016-2027)

11.5.6.2.      Market Revenue and Forecast, by Technique (2016-2027)

11.5.6.3.      Market Revenue and Forecast, by Application (2016-2027)

11.5.6.4.      Market Revenue and Forecast, by End User (2016-2027)

Chapter 12.  Company Profiles

12.1.              Abbott Laboratories

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Becton

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Dickinson and Company

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              bioMérieux SA

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bio-Rad Laboratories, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Danaher Corporation (Beckman Coulter, Inc.)

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              F. Hoffmann-La Roche AG

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Siemens AG

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              QIAGEN N.V.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Sysmex Corporation

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Thermo Fisher Scientific, Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample